Transfection Technologies Market Report and Forecast 2025-2034

Published Jul 27, 2025

Length 350 Pages

SKU # EMAR20319633

Description

The global transfection technologies market size was valued at USD 1137.62 Million in 2024, driven by the development of non-viral delivery systems across the globe. The market size is anticipated to grow at a CAGR of 8.50% during the forecast period of 2025-2034 to achieve a value of USD 2572.14 Million by 2034.

Transfection Technologies: Introduction

Transfection technologies are the techniques and methods that are used to introduce foreign genetic material into cells such as DNA and RNA. These technologies are widely used in gene therapies, drug discovery, and biotechnology. There are several merits and demerits of each transfection method available. Transfection can be achieved through viral or non-viral delivery systems. The most commonly used techniques are chemical transfection, electroporation, and viral-mediated transfection.

Transfection technologies are advancing in our understanding of genetics, facilitating drug discovery, and contributing to the development of innovative therapies. The continuous evolution and optimization of transfection methods contribute to the ongoing breakthroughs in molecular biology and can potentially participate in future advancements in fields such as gene therapy, regenerative medicine, and precision medicine .

Global Transfection Technologies Market Analysis

There are several key trends in the market including the development of non-viral delivery systems which are gaining popularity due to their improved safety profiles and ease of use compared to viral vectors. Additionally, gene editing technologies, cell-specific transfection, high throughput transfection, application specific transfection are also key trend contributing to the global transfection technologies market expansion.

Enhancing cell survival, decreasing, cytotoxicity, and, improving transfection efficiency are the main goals of ongoing research and development. The development of transfection methods that allow for the simultaneous transfection of numerous wells or cell arrays is a result of the necessity for high-throughput screening and analysis in drug discovery and functional genomics. Transfection procedures can be improved and standardized due to the growing integration of transfection technologies with laboratory automation systems, which is likely to aid the transfection technologies market growth. Automated transfection platforms allow accurate and reliable transfection across numerous samples, boosting throughput and reproducibility and accelerating market growth.

Global Transfection Technologies Market Segmentations

The EMR’s report titled “Transfection Technologies Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:

Market Breakup by Method

Reagent-based Method
Instrument-based Method
Other Methods

Market Breakup by Application

Biomedical Research
Therapeutic Delivery
Protein Production

Market Breakup by Products

Reagent
Instrument
Others

Market Breakup by End User

Pharmaceutical and Biotechnology Companies
Contract Research Organizations
Academic and Research Institutes

Market Breakup by Region

North America
Europe
Asia Pacific
Latin America
Middle East and Africa

Global Transfection Technologies Market Overview

The market for transfection technologies has witnessed significant growth in recent years, and is expected to grow in coming years as well. The growth of the market is driven by the increasing demand for genetic research, drug discovery, and gene therapy applications. The market offers a range of transfection methods, including viral and non-viral delivery systems.

The transfection technologies market development is driven by the increasing focus on genetic research which includes functional genomics, proteomics, and personalized medicine. The increasing emphasis on genetic research, including genomics, proteomics, and personalized medicine is driving the demand for transfection technologies propelling the market growth. Recombinant proteins, monoclonal antibodies, and gene treatments are among the biopharmaceuticals that are in high demand. By facilitating the entry of recombinant DNA constructs into host cells for protein expression, transfection technologies play a crucial role in the manufacture of these complex biologics.

Transfection Technologies Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

Lonza Group
Bio-Rad Laboratories, Inc.
Thermo Fisher Scientific
Qiagen NV
Promega Corporation
SignaGen Laboratories
Merck KGaA
Altogen Biosystems
Polyplus-transfection SA
Mirus Bio

*Please Note:* The report will take 5 business days to complete, after order confirmation.

1 Preface: 1.1 Objectives of the Study; 1.2 Key Assumptions; 1.3 Report Coverage – Key Segmentation and Scope; 1.4 Research Methodology
2 Executive Summary
3 Global Transfection Technologies Market Overview: 3.1 Global Transfection Technologies Market Historical Value (2018-2024); 3.2 Global Transfection Technologies Market Forecast Value (2025-2034)
4 Global Transfection Technologies Market Landscape: 4.1 Transfection Technologies: Developers Landscape; 4.1.1 Analysis by Year of Establishment; 4.1.2 Analysis by Company Size; 4.1.3 Analysis by Region; 4.2 Transfection Technologies: Product Landscape; 4.2.1 Analysis by Type; 4.2.2 Analysis by Method; 4.2.3 Analysis by Applications
5 Global Transfection Technologies Market Dynamics: 5.1 Market Drivers and Constraints; 5.2 SWOT Analysis; 5.3 Porter’s Five Forces Model; 5.4 Key Demand Indicators; 5.5 Key Price Indicators; 5.6 Industry Events, Initiatives, and Trends; 5.7 Value Chain Analysis
6 Global Transfection Technologies Market Segmentation: 6.1 Global Transfection Technologies Market by Method; 6.1.1 Market Overview; 6.1.2 Reagent-based Method; 6.1.3 Instrument-based Method; 6.1.4 Other Methods; 6.2 Global Transfection Technologies Market by Application; 6.2.1 Market Overview; 6.2.2 Biomedical Research; 6.2.3 Therapeutic Delivery; 6.2.4 Protein Production; 6.3 Global Transfection Technologies Market by Products; 6.3.1 Market Overview; 6.3.2 Reagent; 6.3.3 Instrument; 6.3.4 Others; 6.4 Global Transfection Technologies Market by End User; 6.4.1 Market Overview; 6.4.2 Pharmaceutical and biotechnology companies; 6.4.3 Contract research organizations; 6.4.4 Academic and research institutes; 6.5 Global Transfection Technologies Market by Region; 6.5.1 Market Overview; 6.5.2 North America; 6.5.3 Europe; 6.5.4 Asia Pacific; 6.5.5 Latin America; 6.5.6 Middle East and Africa
7 North America Transfection Technologies Market: 7.1 Market Share by Country; 7.2 United States of America; 7.3 Canada
8 Europe Transfection Technologies Market: 8.1 Market Share by Country; 8.2 United Kingdom; 8.3 Germany; 8.4 France; 8.5 Italy; 8.6 Others
9 Asia Pacific Transfection Technologies Market: 9.1 Market Share by Country; 9.2 China; 9.3 Japan; 9.4 India; 9.5 ASEAN; 9.6 Australia; 9.7 Others
10 Latin America Transfection Technologies Market: 10.1 Market Share by Country; 10.2 Brazil; 10.3 Argentina; 10.4 Mexico; 10.5 Others
11 Middle East and Africa Transfection Technologies Market: 11.1 Market Share by Country; 11.2 Saudi Arabia; 11.3 United Arab Emirates; 11.4 Nigeria; 11.5 South Africa; 11.6 Others
12 Regulatory Framework: 12.1 Regulatory Overview; 12.1.1 US FDA; 12.1.2 EU EMA; 12.1.3 INDIA CDSCO; 12.1.4 JAPAN PMDA; 12.1.5 Others
13 Patent Analysis: 13.1 Analysis by Type of Patent; 13.2 Analysis by Publication year; 13.3 Analysis by Issuing Authority; 13.4 Analysis by Patent Age; 13.5 Analysis by CPC Analysis; 13.6 Analysis by Patent Valuation; 13.7 Analysis by Key Players
14 Grants Analysis: 14.1 Analysis by year; 14.2 Analysis by Amount Awarded; 14.3 Analysis by Issuing Authority; 14.4 Analysis by Grant Application; 14.5 Analysis by Funding Institute; 14.6 Analysis by NIH Departments; 14.7 Analysis by Recipient Organization
15 Clinical Trials Analysis: 15.1 Analysis by Trial Registration Year; 15.2 Analysis by Trial Status; 15.3 Analysis by Trial Phase; 15.4 Analysis by Therapeutic Area; 15.5 Analysis by Geography
16 Funding and Investment Analysis: 16.1 Analysis by Funding Instances; 16.2 Analysis by Type of Funding; 16.3 Analysis by Funding Amount; 16.4 Analysis by Leading Players; 16.5 Analysis by Leading Investors; 16.6 Analysis by Geography
17 Partnership and Collaborations Analysis: 17.1 Analysis by Partnership Instances; 17.2 Analysis by Type of Partnership; 17.3 Analysis by Leading Players; 17.4 Analysis by Geography
18 Supplier Landscape: 18.1 Lonza Group; 18.1.1 Financial Analysis; 18.1.2 Product Portfolio; 18.1.3 Demographic Reach and Achievements; 18.1.4 Mergers and Acquisitions; 18.1.5 Certifications; 18.2 Bio-Rad Laboratories, Inc.; 18.2.1 Financial Analysis; 18.2.2 Product Portfolio; 18.2.3 Demographic Reach and Achievements; 18.2.4 Mergers and Acquisitions; 18.2.5 Certifications; 18.3 Thermo Fisher Scientific; 18.3.1 Financial Analysis; 18.3.2 Product Portfolio; 18.3.3 Demographic Reach and Achievements; 18.3.4 Mergers and Acquisitions; 18.3.5 Certifications; 18.4 Qiagen NV; 18.4.1 Financial Analysis; 18.4.2 Product Portfolio; 18.4.3 Demographic Reach and Achievements; 18.4.4 Mergers and Acquisitions; 18.4.5 Certifications; 18.5 Promega Corporation; 18.5.1 Financial Analysis; 18.5.2 Product Portfolio; 18.5.3 Demographic Reach and Achievements; 18.5.4 Mergers and Acquisitions; 18.5.5 Certifications; 18.6 SignaGen Laboratories; 18.6.1 Financial Analysis; 18.6.2 Product Portfolio; 18.6.3 Demographic Reach and Achievements; 18.6.4 Mergers and Acquisitions; 18.6.5 Certifications; 18.7 Merck KGaA; 18.7.1 Financial Analysis; 18.7.2 Product Portfolio; 18.7.3 Demographic Reach and Achievements; 18.7.4 Mergers and Acquisitions; 18.7.5 Certifications; 18.8 Altogen Biosystems; 18.8.1 Financial Analysis; 18.8.2 Product Portfolio; 18.8.3 Demographic Reach and Achievements; 18.8.4 Mergers and Acquisitions; 18.8.5 Certifications; 18.9 Polyplus-transfection SA; 18.9.1 Financial Analysis; 18.9.2 Product Portfolio; 18.9.3 Demographic Reach and Achievements; 18.9.4 Mergers and Acquisitions; 18.9.5 Certifications; 18.10 Mirus Bio; 18.10.1 Financial Analysis; 18.10.2 Product Portfolio; 18.10.3 Demographic Reach and Achievements; 18.10.4 Mergers and Acquisitions; 18.10.5 Certifications
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight): 20.1 Very Small Companies; 20.2 Small Companies; 20.3 Mid-Sized Companies; 20.4 Large Companies; 20.5 Very Large Companies
21 Payment Methods (Additional Insight): 21.1 Government Funded; 21.2 Private Insurance; 21.3 Out-of-Pocket

Pricing

Currency Rates

Single User Email from Publisher $4,949
Global Site License Email from Publisher $6,969

How Do Licenses Work?

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now